Literature DB >> 16024949

Nasolacrimal drainage obstruction after radioiodine therapy: case report and a review of the literature.

Holger Brockmann1, Kai Wilhelm, Alexius Joe, Holger Palmedo, Hans-Juergen Biersack.   

Abstract

The authors report a 54-year-old woman with papillary thyroid carcinoma (Lindsay type, pT2 N0 M1) with pulmonary metastases. After a total thyroidectomy, a series of 3 radioiodine therapies were performed with a cumulative dose of 700 mCi I-131. After termination of the therapy, the patient was initially without complaints, but approximately 6 months later, epiphora was noted, first only of the right eye and eventually of both eyes. A whole-body I-131 scan performed 1 year after final radioiodine therapy showed atypical tracer accumulation in both medial orbital regions. This finding was new compared with the scan that was done 1 year before. Dacryocystography revealed bilateral occlusion of the lacrimal drainage system. A review of the literature shows that epiphora and lacrimal duct alterations are rarely investigated and potentially underestimated side effects after high-dose radioiodine therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024949     DOI: 10.1097/01.rlu.0000170013.84378.2a

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.

Authors:  Jacqueline Jonklaas
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

2.  Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases.

Authors:  Khalid Hussain Al-Qahtani; Mushabbab Al Asiri; Mutahir A Tunio; Naji J Aljohani; Yasser Bayoumi; Iqbal Munir; Ayman AlAyoubi
Journal:  Clin Ophthalmol       Date:  2014-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.